Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AD 1590

Known as: AD-1590 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
AbstractsThe site of antipyretic action of AD-1590 in the sequential process involved in the development of fever caused by… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
1988
1988
A double-blind study of the antipyretic analgesic AD-1590 20 mg (Group A) was conducted to evaluate its utility in pain after… Expand
Is this relevant?
1988
1988
Authors have reported that the oral potency ratio of AD-1590 to indomethacin varies with the animal models employed; the ratio is… Expand
Is this relevant?
1988
1988
Effect of AD-1590 on allergic inflammations was investigated. AD-1590 and indomethacin at an oral dosage as high as 32 mg/kg did… Expand
Is this relevant?
1986
1986
Stabilization of AD-1590 in an oleaginous suppository by complexation with β-cyclodextrin (β-CvD) was investigated. Suppositories… Expand
Is this relevant?
1986
1986
The influence of pharmaceutical properties on the gastric lesions induced by AD-1590 (AD), a non-steroidal anti-inflammatory drug… Expand
Is this relevant?
1986
1986
The inhibitory activity of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl) propionic acid (AD-1590) against prostaglandin… Expand
Is this relevant?
1985
1985
The inhibition of prostaglandin generation by AD-1590 was investigated in the rabbit brain in-vivo. AD-1590 (0.4 mg kg-1 i.v… Expand
Is this relevant?
1984
1984
The antipyretic activity of AD-1590 (2-[8-methyl-10,11-0xodibenz[b,f]oxepin-2-yl]propionic acid), a non-steroidal anti… Expand
Is this relevant?
1983
1983
Anti-inflammatory, analgesic, antipyretic and gastrointestinal ulcerogenic activities of 2-(8-methyl-10,11-dihydro-11-oxodibenz(b… Expand
Is this relevant?